Advanced Search
ORIGINAL ARTICLE
Korean J Pediatr 1995 October;38(10) :1384-1393.
Effect of Prophylactic Treatment of High Doses Recombinant Human Erythropoietin on Anemia in Premature Infants
Soon Seong Park (Park SS), Seong Ho Hong (Hong SH), Hye Lime Jung (Jung HL), Dong Hyeok Keum (Keum DH)
Department of Pediatrics, Kangbuk Samsung Hospital, Samsung Medical Center, Seoul, Korea
Copyright © 1995 by The Korean Pediatric Society
ABSTRACT
Purpose : This study was conducted to determine whether prophylatic treatment with recombinant human erythropoietin(rHuEPO) could prevent anemia and reduce the need for blood transfusion in premature infants. Methods : This study was conducted from May, 1992 to July 1994. We randomly assigned 24 premature infants with gestational age less than 34 weeks and birth weight less than 2.0kg. After having assigned 13 infants into treatment group and 11 infants into control group, rHuEPO was administered intravenously or subcutaneously three times a week to 13 treatment infants at dose of 12ooIU/kg per week for 4 weeks, starting at second day of life. We have checked hemoglobin, hematocrit, reticulocyte, setum ferritin, serum erythropoietin in both control and treatment group at the time of the birth and weekly for 4 weeks after birth. Results : The two groups had similar birth weights and clinical variables. During the 4 weeks of observation, the treated infants required fewer blood transfusion(0.30.6 vs 1.01.3 : p<0.05). Hemoglobin and hematocrit values were higher in the treated group(12.11.3% vs 10.51.2% ; p<0.05 and 38.24.8% vs 31.54.2% ; p<0.05). Reticulocyte and serum erythropoietin values were higher in the treated group(5.73.2% vs 1.7 0.7% ; p<0.05 and 132.47mU/ml 96.18mU/ml96.18mU/ml vs 5.66mU/ml3.27mU/ml ; p<0.05). No prominent adverse effects of intravenously or subcutaneously administered rHuEPO were noted. Conclusion : Our data indicate that prophylactic administration of high dose rHuEPO is safe and effective in stimulating erythropoiesis and reducing the requirement for blood transfusions in premature infants.
Keywords: rythropoiethin | Premature infant | Transfusion
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail
  Print
Share:      
METRICS
897
View
0
Download
Antithrombin III in the Diagnosis and Treatment of Disseminated Intravascular Coagulation in Premature Infants  2004 July;47(7)
Effect of Parenteral Nutrition Guideline Changes on Neonatal Sepsis in Premature Infants  2001 June;44(6)
The Study of Transplacental Transfer of Immunoglobulin G in Premature Infants  1998 June;41(6)
Prophylactic Treatment of Anemia of Prematurity with Recombinant Human Erythropoietin and High Doses of Iron  1997 March;40(3)
Effect of Recombinant Human Erythropoietin on the Anemia of Premature Infants  1996 May;39(5)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at http://submit.kjp.or.kr, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact: kjpped@gmail.com.
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail: kjpped@gmail.com
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.